Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.76
-0.12 (-1.01%)
Sep 10, 2025, 12:07 PM - Market open
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.26 billion as of September 10, 2025. Its market cap has decreased by -45.97% in one year.
Market Cap
1.26B
Enterprise Value
747.37M
1-Year Change
-45.97%
Ranking
Category
Stock Price
$11.76
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.26B, an increase of 66.65%. That is a compound annual growth rate of 5.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 1.28B | 7.38% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.85B |
| Johnson & Johnson | 426.18B |
| AbbVie | 371.72B |
| UnitedHealth Group | 315.10B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 229.65B |